Enlace al volante, el cual detalla los ponentes y las presentaciones.
Gynuity at the FIGO World Congress of Gynecology and Obstetrics 2018
In October 2018, Rio de Janeiro will provide the setting for the XXII FIGO World Congress of Gynecology and Obstetrics, an important triennial event attracting leading experts in women’s health from around the world. Gynuity has developed an exciting program featuring highlights from our global research and collaborative projects on a range of reproductive and maternal health topics, including abortion and postabortion care, postpartum hemorrhage and pre-eclampsia/eclampsia. If you are travelling to Brazil for the Congress, our team looks forward to seeing you. Our at-a-glance program is available to view here.
The Atlantic magazine features Gynuity research in an article about online abortion pills in the US
An article published in the magazine, The Atlantic, examines the practice of buying abortion pills online and features recent research by Gynuity Health Projects and Plan C.
Our study found that obtaining mifepristone and misoprostol from online vendors that do not require a prescription is feasible in the United States. Given our findings, we expect that some people for whom clinic-based abortion is not easily available or acceptable may consider self-sourcing pills from the internet to be a rational option.
Gynuity Health Project's E-news bulletin shares information about the work of our staff and collaborators in the field. We report on recent and upcoming meetings, highlights of new and ongoing projects, recently published articles and materials, and some of our key achievements. We will also have a "Spotlight on..." feature in each newsletter providing an in-depth look at a specific project.
Click here to view our May 2018 E-news bulletin
Click here to view our December 2017 E-news bulletin
Click here to view our September 2017 E-news bulletin
Click here to view our May 2017 E-news bulletin
20th Annual Mifepristone Medical Abortion Meeting
New York, NY, June 4-5
Over 130 clinicians, researchers, donors, reproductive health advocates, and pharmaceutical representatives gathered this June for Gynuity’s 20th annual mifepristone medical abortion meeting, “Mifepristone Medical Abortion: Responding to a World in Flux.” Participants heard updates about new science and programs designed to expand access to mifepristone from domestic and international colleagues. During small breakout groups, colleagues joined in-depth conversations about mifepristone reversal messages, providing medical abortion to displaced persons, streamlining 2nd trimester abortion, communications and messaging for popular media, and exploring telemedicine abortion globally. The second day of the meeting featured panels that examined the possibilities and problems of increased autonomy in using medical abortion. The sessions explored different types of services that could increase autonomy, disposal of products of conception as gestational age rises, and new technologies that could facilitate self-induced abortion. Thank you to our friends and colleagues for another inspiring meeting!